Investigator Initiated Trial (IIT) Service for Institutions

Fact Sheet

Pharmaceutical and biotech companies approve and fund Investigator Initiated Trials (IITs) to meet a number of clinical objectives while building strong relationships with key opinion leaders. Conducting these types of trials enables pharma to capture insightful data on the performance of their drug products across other therapeutic areas.

Setting up the clinical supply chain for these trials can present complexities when taking into account regulatory requirements and other considerations such as label and packaging design, label text translations, global distribution and resupply requests.

Download this fact sheet to learn how our IIT service offers comprehensive oversight and management of all clinical supply activities for a portfolio of Investigator Initiated Trials.